FATE THERAPEUTICS INC Business Finance Contracts & Agreements
36 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Loan Agreements (5)
- Note Agreements (4)
- Purchase Agreements (3)
- Registration Rights Agreements (2)
- Stock Agreements (5)
- Underwriting Agreements (8)
- Warrant Agreements (7)
- Securities Purchase Agreement, dated as of March 19, 2024, between Fate Therapeutics, Inc. and RedCo II Master Fund, L.P (Filed With SEC on March 21, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 21, 2024)
- Underwriting Agreement, dated as of March 19, 2024, among Fate Therapeutics, Inc., BofA Securities, Inc., Jefferies LLC and Leerink Partners LLC, as representatives of the... (Filed With SEC on March 21, 2024)
- Forms of Restricted Stock Unit Award Agreement under Fate Therapeutics, Inc. Inducement Equity Plan (Filed With SEC on February 24, 2021)
- Forms of Stock Option Agreement under Fate Therapeutics, Inc. Inducement Equity Plan (Filed With SEC on February 24, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on January 8, 2021)
- Underwriting Agreement, dated January 5, 2021 (Filed With SEC on January 8, 2021)
- Underwriting Agreement, dated June 8, 2020 (Filed With SEC on June 10, 2020)
- Underwriting Agreement, dated September 11, 2019 (Filed With SEC on September 13, 2019)
- Underwriting Agreement, dated September 20, 2018 (Filed With SEC on September 21, 2018)
- Underwriting Agreement, dated December 12, 2017 (Filed With SEC on December 14, 2017)
- First Amendment to Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated July 14, 2017 (Filed With SEC on August 14, 2017)
- Warrant to Purchase Common Stock issued to Silicon Valley Bank on July 14, 2017 (Filed With SEC on August 14, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 22, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 8, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 8, 2016)
- FATE THERAPEUTICS, INC. AMENDMENT TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 5, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on August 5, 2015)
- 6,000,000 Shares Fate Therapeutics, Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT May 20, 2015 (Filed With SEC on May 21, 2015)
- WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 5, 2014)
- AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on August 5, 2014)
- FATE THERAPEUTICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 16, 2013)
- FATE THERAPEUTICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 3, 2013)
- [ ] Shares FATE THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 3, 2013)
- NOTE PURCHASE AGREEMENT (Filed With SEC on August 14, 2013)
- NOTE PURCHASE AGREEMENT (Filed With SEC on August 14, 2013)
- FATE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 14, 2013)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 14, 2013)
- AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 14, 2013)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 14, 2013)
- FATE THERAPEUTICS, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- FATETHERAPEUTICS, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 14, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 14, 2013)
- FIRST AMENDMENT TO WARRANT TO PURCHASE STOCK DATED JANUARY 5, 2009 (Filed With SEC on August 14, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 14, 2013)
